Icrucumab Antibody
Icrucumab (IMC-18F1) is a humanized IgG1 monoclonal antibody that inhibits vascular endothelial growth factor receptor-1 (VEGFR-1) . It has demonstrated antitumor activity and has been investigated in preclinical models and clinical trials for metastatic colorectal cancer.
Product Specifications
Product Name Alternative
VEGFR, IMC-18F1, LY 3012212
Target
VEGFR
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Signal Transduction
Concentration
5.97 mg/mL
Purity
>95% (May vary between batches)
Molecular Weight
150 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
